Global Gene Therapy On Cardiovascular Disease Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Page: 109

Published Date: 02 Jan 2024

Category: Medical Devices & Consumables

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

According to our (Global Info Research) latest study, the global Gene Therapy On Cardiovascular Disease market size was valued at USD 13 million in 2023 and is forecast to a readjusted size of USD 1073.1 million by 2030 with a CAGR of 87.1% during review period.

Gene therapy is an experimental technique that uses genes to treat or prevent disease. In the future, this technique may allow doctors to treat a disorder by inserting a gene into a patient's cells instead of using drugs or surgery.

Although several conventional small-molecule treatments are available for common cardiovascular problems, gene therapy is a potential treatment option for acquired and inherited cardiovascular diseases that remain with unmet clinical needs.

Global key players of Gene Therapy On Cardiovascular Disease include Biogen, Novartis, Gilead Sciences, Sarepta Therapeutics, Alnylam Pharmaceuticals and Amgen, etc. Top three players occupy for a share about 76%. In terms of product, Non-Viral Gene Therapy is the largest segment, with a share over 100%. In terms of application, Vascular Disease is the largest market, with a share over 100%.

The Global Info Research report includes an overview of the development of the Gene Therapy On Cardiovascular Disease industry chain, the market status of Heart Disease (Viral Gene Therapy, Non-Viral Gene Therapy), Vascular Disease (Viral Gene Therapy, Non-Viral Gene Therapy), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Gene Therapy On Cardiovascular Disease.

Regionally, the report analyzes the Gene Therapy On Cardiovascular Disease markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Gene Therapy On Cardiovascular Disease market, with robust domestic demand, supportive policies, and a strong manufacturing base.

Key Features:
The report presents comprehensive understanding of the Gene Therapy On Cardiovascular Disease market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Gene Therapy On Cardiovascular Disease industry.

The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Viral Gene Therapy, Non-Viral Gene Therapy).

Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Gene Therapy On Cardiovascular Disease market.

Regional Analysis: The report involves examining the Gene Therapy On Cardiovascular Disease market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.

Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Gene Therapy On Cardiovascular Disease market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.

The report also involves a more granular approach to Gene Therapy On Cardiovascular Disease:
Company Analysis: Report covers individual Gene Therapy On Cardiovascular Disease players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.

Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Gene Therapy On Cardiovascular Disease This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Heart Disease, Vascular Disease).

Technology Analysis: Report covers specific technologies relevant to Gene Therapy On Cardiovascular Disease. It assesses the current state, advancements, and potential future developments in Gene Therapy On Cardiovascular Disease areas.

Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Gene Therapy On Cardiovascular Disease market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.

Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.

Market Segmentation
Gene Therapy On Cardiovascular Disease market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.

Market segment by Type
Viral Gene Therapy
Non-Viral Gene Therapy

Market segment by Application
Heart Disease
Vascular Disease

Market segment by players, this report covers
Biogen
Novartis
Gilead Sciences
Sarepta Therapeutics
Alnylam Pharmaceuticals
Amgen
Spark Therapeutics
Akcea Therapeutics
bluebird bio
Sunway Biotech
SIBIONO
AnGes
Orchard Therapeutics
Human Stem Cells Institute

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Gene Therapy On Cardiovascular Disease product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Gene Therapy On Cardiovascular Disease, with revenue, gross margin and global market share of Gene Therapy On Cardiovascular Disease from 2019 to 2024.
Chapter 3, the Gene Therapy On Cardiovascular Disease competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Gene Therapy On Cardiovascular Disease market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Gene Therapy On Cardiovascular Disease.
Chapter 13, to describe Gene Therapy On Cardiovascular Disease research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Gene Therapy On Cardiovascular Disease
    1.2 Market Estimation Caveats and Base Year
    1.3 Classification of Gene Therapy On Cardiovascular Disease by Type
        1.3.1 Overview: Global Gene Therapy On Cardiovascular Disease Market Size by Type: 2019 Versus 2023 Versus 2030
        1.3.2 Global Gene Therapy On Cardiovascular Disease Consumption Value Market Share by Type in 2023
        1.3.3 Viral Gene Therapy
        1.3.4 Non-Viral Gene Therapy
    1.4 Global Gene Therapy On Cardiovascular Disease Market by Application
        1.4.1 Overview: Global Gene Therapy On Cardiovascular Disease Market Size by Application: 2019 Versus 2023 Versus 2030
        1.4.2 Heart Disease
        1.4.3 Vascular Disease
    1.5 Global Gene Therapy On Cardiovascular Disease Market Size & Forecast
    1.6 Global Gene Therapy On Cardiovascular Disease Market Size and Forecast by Region
        1.6.1 Global Gene Therapy On Cardiovascular Disease Market Size by Region: 2019 VS 2023 VS 2030
        1.6.2 Global Gene Therapy On Cardiovascular Disease Market Size by Region, (2019-2030)
        1.6.3 North America Gene Therapy On Cardiovascular Disease Market Size and Prospect (2019-2030)
        1.6.4 Europe Gene Therapy On Cardiovascular Disease Market Size and Prospect (2019-2030)
        1.6.5 Asia-Pacific Gene Therapy On Cardiovascular Disease Market Size and Prospect (2019-2030)
        1.6.6 South America Gene Therapy On Cardiovascular Disease Market Size and Prospect (2019-2030)
        1.6.7 Middle East and Africa Gene Therapy On Cardiovascular Disease Market Size and Prospect (2019-2030)

2 Company Profiles
    2.1 Biogen
        2.1.1 Biogen Details
        2.1.2 Biogen Major Business
        2.1.3 Biogen Gene Therapy On Cardiovascular Disease Product and Solutions
        2.1.4 Biogen Gene Therapy On Cardiovascular Disease Revenue, Gross Margin and Market Share (2019-2024)
        2.1.5 Biogen Recent Developments and Future Plans
    2.2 Novartis
        2.2.1 Novartis Details
        2.2.2 Novartis Major Business
        2.2.3 Novartis Gene Therapy On Cardiovascular Disease Product and Solutions
        2.2.4 Novartis Gene Therapy On Cardiovascular Disease Revenue, Gross Margin and Market Share (2019-2024)
        2.2.5 Novartis Recent Developments and Future Plans
    2.3 Gilead Sciences
        2.3.1 Gilead Sciences Details
        2.3.2 Gilead Sciences Major Business
        2.3.3 Gilead Sciences Gene Therapy On Cardiovascular Disease Product and Solutions
        2.3.4 Gilead Sciences Gene Therapy On Cardiovascular Disease Revenue, Gross Margin and Market Share (2019-2024)
        2.3.5 Gilead Sciences Recent Developments and Future Plans
    2.4 Sarepta Therapeutics
        2.4.1 Sarepta Therapeutics Details
        2.4.2 Sarepta Therapeutics Major Business
        2.4.3 Sarepta Therapeutics Gene Therapy On Cardiovascular Disease Product and Solutions
        2.4.4 Sarepta Therapeutics Gene Therapy On Cardiovascular Disease Revenue, Gross Margin and Market Share (2019-2024)
        2.4.5 Sarepta Therapeutics Recent Developments and Future Plans
    2.5 Alnylam Pharmaceuticals
        2.5.1 Alnylam Pharmaceuticals Details
        2.5.2 Alnylam Pharmaceuticals Major Business
        2.5.3 Alnylam Pharmaceuticals Gene Therapy On Cardiovascular Disease Product and Solutions
        2.5.4 Alnylam Pharmaceuticals Gene Therapy On Cardiovascular Disease Revenue, Gross Margin and Market Share (2019-2024)
        2.5.5 Alnylam Pharmaceuticals Recent Developments and Future Plans
    2.6 Amgen
        2.6.1 Amgen Details
        2.6.2 Amgen Major Business
        2.6.3 Amgen Gene Therapy On Cardiovascular Disease Product and Solutions
        2.6.4 Amgen Gene Therapy On Cardiovascular Disease Revenue, Gross Margin and Market Share (2019-2024)
        2.6.5 Amgen Recent Developments and Future Plans
    2.7 Spark Therapeutics
        2.7.1 Spark Therapeutics Details
        2.7.2 Spark Therapeutics Major Business
        2.7.3 Spark Therapeutics Gene Therapy On Cardiovascular Disease Product and Solutions
        2.7.4 Spark Therapeutics Gene Therapy On Cardiovascular Disease Revenue, Gross Margin and Market Share (2019-2024)
        2.7.5 Spark Therapeutics Recent Developments and Future Plans
    2.8 Akcea Therapeutics
        2.8.1 Akcea Therapeutics Details
        2.8.2 Akcea Therapeutics Major Business
        2.8.3 Akcea Therapeutics Gene Therapy On Cardiovascular Disease Product and Solutions
        2.8.4 Akcea Therapeutics Gene Therapy On Cardiovascular Disease Revenue, Gross Margin and Market Share (2019-2024)
        2.8.5 Akcea Therapeutics Recent Developments and Future Plans
    2.9 bluebird bio
        2.9.1 bluebird bio Details
        2.9.2 bluebird bio Major Business
        2.9.3 bluebird bio Gene Therapy On Cardiovascular Disease Product and Solutions
        2.9.4 bluebird bio Gene Therapy On Cardiovascular Disease Revenue, Gross Margin and Market Share (2019-2024)
        2.9.5 bluebird bio Recent Developments and Future Plans
    2.10 Sunway Biotech
        2.10.1 Sunway Biotech Details
        2.10.2 Sunway Biotech Major Business
        2.10.3 Sunway Biotech Gene Therapy On Cardiovascular Disease Product and Solutions
        2.10.4 Sunway Biotech Gene Therapy On Cardiovascular Disease Revenue, Gross Margin and Market Share (2019-2024)
        2.10.5 Sunway Biotech Recent Developments and Future Plans
    2.11 SIBIONO
        2.11.1 SIBIONO Details
        2.11.2 SIBIONO Major Business
        2.11.3 SIBIONO Gene Therapy On Cardiovascular Disease Product and Solutions
        2.11.4 SIBIONO Gene Therapy On Cardiovascular Disease Revenue, Gross Margin and Market Share (2019-2024)
        2.11.5 SIBIONO Recent Developments and Future Plans
    2.12 AnGes
        2.12.1 AnGes Details
        2.12.2 AnGes Major Business
        2.12.3 AnGes Gene Therapy On Cardiovascular Disease Product and Solutions
        2.12.4 AnGes Gene Therapy On Cardiovascular Disease Revenue, Gross Margin and Market Share (2019-2024)
        2.12.5 AnGes Recent Developments and Future Plans
    2.13 Orchard Therapeutics
        2.13.1 Orchard Therapeutics Details
        2.13.2 Orchard Therapeutics Major Business
        2.13.3 Orchard Therapeutics Gene Therapy On Cardiovascular Disease Product and Solutions
        2.13.4 Orchard Therapeutics Gene Therapy On Cardiovascular Disease Revenue, Gross Margin and Market Share (2019-2024)
        2.13.5 Orchard Therapeutics Recent Developments and Future Plans
    2.14 Human Stem Cells Institute
        2.14.1 Human Stem Cells Institute Details
        2.14.2 Human Stem Cells Institute Major Business
        2.14.3 Human Stem Cells Institute Gene Therapy On Cardiovascular Disease Product and Solutions
        2.14.4 Human Stem Cells Institute Gene Therapy On Cardiovascular Disease Revenue, Gross Margin and Market Share (2019-2024)
        2.14.5 Human Stem Cells Institute Recent Developments and Future Plans

3 Market Competition, by Players
    3.1 Global Gene Therapy On Cardiovascular Disease Revenue and Share by Players (2019-2024)
    3.2 Market Share Analysis (2023)
        3.2.1 Market Share of Gene Therapy On Cardiovascular Disease by Company Revenue
        3.2.2 Top 3 Gene Therapy On Cardiovascular Disease Players Market Share in 2023
        3.2.3 Top 6 Gene Therapy On Cardiovascular Disease Players Market Share in 2023
    3.3 Gene Therapy On Cardiovascular Disease Market: Overall Company Footprint Analysis
        3.3.1 Gene Therapy On Cardiovascular Disease Market: Region Footprint
        3.3.2 Gene Therapy On Cardiovascular Disease Market: Company Product Type Footprint
        3.3.3 Gene Therapy On Cardiovascular Disease Market: Company Product Application Footprint
    3.4 New Market Entrants and Barriers to Market Entry
    3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type
    4.1 Global Gene Therapy On Cardiovascular Disease Consumption Value and Market Share by Type (2019-2024)
    4.2 Global Gene Therapy On Cardiovascular Disease Market Forecast by Type (2025-2030)

5 Market Size Segment by Application
    5.1 Global Gene Therapy On Cardiovascular Disease Consumption Value Market Share by Application (2019-2024)
    5.2 Global Gene Therapy On Cardiovascular Disease Market Forecast by Application (2025-2030)

6 North America
    6.1 North America Gene Therapy On Cardiovascular Disease Consumption Value by Type (2019-2030)
    6.2 North America Gene Therapy On Cardiovascular Disease Consumption Value by Application (2019-2030)
    6.3 North America Gene Therapy On Cardiovascular Disease Market Size by Country
        6.3.1 North America Gene Therapy On Cardiovascular Disease Consumption Value by Country (2019-2030)
        6.3.2 United States Gene Therapy On Cardiovascular Disease Market Size and Forecast (2019-2030)
        6.3.3 Canada Gene Therapy On Cardiovascular Disease Market Size and Forecast (2019-2030)
        6.3.4 Mexico Gene Therapy On Cardiovascular Disease Market Size and Forecast (2019-2030)

7 Europe
    7.1 Europe Gene Therapy On Cardiovascular Disease Consumption Value by Type (2019-2030)
    7.2 Europe Gene Therapy On Cardiovascular Disease Consumption Value by Application (2019-2030)
    7.3 Europe Gene Therapy On Cardiovascular Disease Market Size by Country
        7.3.1 Europe Gene Therapy On Cardiovascular Disease Consumption Value by Country (2019-2030)
        7.3.2 Germany Gene Therapy On Cardiovascular Disease Market Size and Forecast (2019-2030)
        7.3.3 France Gene Therapy On Cardiovascular Disease Market Size and Forecast (2019-2030)
        7.3.4 United Kingdom Gene Therapy On Cardiovascular Disease Market Size and Forecast (2019-2030)
        7.3.5 Russia Gene Therapy On Cardiovascular Disease Market Size and Forecast (2019-2030)
        7.3.6 Italy Gene Therapy On Cardiovascular Disease Market Size and Forecast (2019-2030)

8 Asia-Pacific
    8.1 Asia-Pacific Gene Therapy On Cardiovascular Disease Consumption Value by Type (2019-2030)
    8.2 Asia-Pacific Gene Therapy On Cardiovascular Disease Consumption Value by Application (2019-2030)
    8.3 Asia-Pacific Gene Therapy On Cardiovascular Disease Market Size by Region
        8.3.1 Asia-Pacific Gene Therapy On Cardiovascular Disease Consumption Value by Region (2019-2030)
        8.3.2 China Gene Therapy On Cardiovascular Disease Market Size and Forecast (2019-2030)
        8.3.3 Japan Gene Therapy On Cardiovascular Disease Market Size and Forecast (2019-2030)
        8.3.4 South Korea Gene Therapy On Cardiovascular Disease Market Size and Forecast (2019-2030)
        8.3.5 India Gene Therapy On Cardiovascular Disease Market Size and Forecast (2019-2030)
        8.3.6 Southeast Asia Gene Therapy On Cardiovascular Disease Market Size and Forecast (2019-2030)
        8.3.7 Australia Gene Therapy On Cardiovascular Disease Market Size and Forecast (2019-2030)

9 South America
    9.1 South America Gene Therapy On Cardiovascular Disease Consumption Value by Type (2019-2030)
    9.2 South America Gene Therapy On Cardiovascular Disease Consumption Value by Application (2019-2030)
    9.3 South America Gene Therapy On Cardiovascular Disease Market Size by Country
        9.3.1 South America Gene Therapy On Cardiovascular Disease Consumption Value by Country (2019-2030)
        9.3.2 Brazil Gene Therapy On Cardiovascular Disease Market Size and Forecast (2019-2030)
        9.3.3 Argentina Gene Therapy On Cardiovascular Disease Market Size and Forecast (2019-2030)

10 Middle East & Africa
    10.1 Middle East & Africa Gene Therapy On Cardiovascular Disease Consumption Value by Type (2019-2030)
    10.2 Middle East & Africa Gene Therapy On Cardiovascular Disease Consumption Value by Application (2019-2030)
    10.3 Middle East & Africa Gene Therapy On Cardiovascular Disease Market Size by Country
        10.3.1 Middle East & Africa Gene Therapy On Cardiovascular Disease Consumption Value by Country (2019-2030)
        10.3.2 Turkey Gene Therapy On Cardiovascular Disease Market Size and Forecast (2019-2030)
        10.3.3 Saudi Arabia Gene Therapy On Cardiovascular Disease Market Size and Forecast (2019-2030)
        10.3.4 UAE Gene Therapy On Cardiovascular Disease Market Size and Forecast (2019-2030)

11 Market Dynamics
    11.1 Gene Therapy On Cardiovascular Disease Market Drivers
    11.2 Gene Therapy On Cardiovascular Disease Market Restraints
    11.3 Gene Therapy On Cardiovascular Disease Trends Analysis
    11.4 Porters Five Forces Analysis
        11.4.1 Threat of New Entrants
        11.4.2 Bargaining Power of Suppliers
        11.4.3 Bargaining Power of Buyers
        11.4.4 Threat of Substitutes
        11.4.5 Competitive Rivalry

12 Industry Chain Analysis
    12.1 Gene Therapy On Cardiovascular Disease Industry Chain
    12.2 Gene Therapy On Cardiovascular Disease Upstream Analysis
    12.3 Gene Therapy On Cardiovascular Disease Midstream Analysis
    12.4 Gene Therapy On Cardiovascular Disease Downstream Analysis

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology
    14.2 Research Process and Data Source
    14.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Gene Therapy On Cardiovascular Disease Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Table 2. Global Gene Therapy On Cardiovascular Disease Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
    Table 3. Global Gene Therapy On Cardiovascular Disease Consumption Value by Region (2019-2024) & (USD Million)
    Table 4. Global Gene Therapy On Cardiovascular Disease Consumption Value by Region (2025-2030) & (USD Million)
    Table 5. Biogen Company Information, Head Office, and Major Competitors
    Table 6. Biogen Major Business
    Table 7. Biogen Gene Therapy On Cardiovascular Disease Product and Solutions
    Table 8. Biogen Gene Therapy On Cardiovascular Disease Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 9. Biogen Recent Developments and Future Plans
    Table 10. Novartis Company Information, Head Office, and Major Competitors
    Table 11. Novartis Major Business
    Table 12. Novartis Gene Therapy On Cardiovascular Disease Product and Solutions
    Table 13. Novartis Gene Therapy On Cardiovascular Disease Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 14. Novartis Recent Developments and Future Plans
    Table 15. Gilead Sciences Company Information, Head Office, and Major Competitors
    Table 16. Gilead Sciences Major Business
    Table 17. Gilead Sciences Gene Therapy On Cardiovascular Disease Product and Solutions
    Table 18. Gilead Sciences Gene Therapy On Cardiovascular Disease Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 19. Gilead Sciences Recent Developments and Future Plans
    Table 20. Sarepta Therapeutics Company Information, Head Office, and Major Competitors
    Table 21. Sarepta Therapeutics Major Business
    Table 22. Sarepta Therapeutics Gene Therapy On Cardiovascular Disease Product and Solutions
    Table 23. Sarepta Therapeutics Gene Therapy On Cardiovascular Disease Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 24. Sarepta Therapeutics Recent Developments and Future Plans
    Table 25. Alnylam Pharmaceuticals Company Information, Head Office, and Major Competitors
    Table 26. Alnylam Pharmaceuticals Major Business
    Table 27. Alnylam Pharmaceuticals Gene Therapy On Cardiovascular Disease Product and Solutions
    Table 28. Alnylam Pharmaceuticals Gene Therapy On Cardiovascular Disease Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 29. Alnylam Pharmaceuticals Recent Developments and Future Plans
    Table 30. Amgen Company Information, Head Office, and Major Competitors
    Table 31. Amgen Major Business
    Table 32. Amgen Gene Therapy On Cardiovascular Disease Product and Solutions
    Table 33. Amgen Gene Therapy On Cardiovascular Disease Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 34. Amgen Recent Developments and Future Plans
    Table 35. Spark Therapeutics Company Information, Head Office, and Major Competitors
    Table 36. Spark Therapeutics Major Business
    Table 37. Spark Therapeutics Gene Therapy On Cardiovascular Disease Product and Solutions
    Table 38. Spark Therapeutics Gene Therapy On Cardiovascular Disease Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 39. Spark Therapeutics Recent Developments and Future Plans
    Table 40. Akcea Therapeutics Company Information, Head Office, and Major Competitors
    Table 41. Akcea Therapeutics Major Business
    Table 42. Akcea Therapeutics Gene Therapy On Cardiovascular Disease Product and Solutions
    Table 43. Akcea Therapeutics Gene Therapy On Cardiovascular Disease Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 44. Akcea Therapeutics Recent Developments and Future Plans
    Table 45. bluebird bio Company Information, Head Office, and Major Competitors
    Table 46. bluebird bio Major Business
    Table 47. bluebird bio Gene Therapy On Cardiovascular Disease Product and Solutions
    Table 48. bluebird bio Gene Therapy On Cardiovascular Disease Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 49. bluebird bio Recent Developments and Future Plans
    Table 50. Sunway Biotech Company Information, Head Office, and Major Competitors
    Table 51. Sunway Biotech Major Business
    Table 52. Sunway Biotech Gene Therapy On Cardiovascular Disease Product and Solutions
    Table 53. Sunway Biotech Gene Therapy On Cardiovascular Disease Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 54. Sunway Biotech Recent Developments and Future Plans
    Table 55. SIBIONO Company Information, Head Office, and Major Competitors
    Table 56. SIBIONO Major Business
    Table 57. SIBIONO Gene Therapy On Cardiovascular Disease Product and Solutions
    Table 58. SIBIONO Gene Therapy On Cardiovascular Disease Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 59. SIBIONO Recent Developments and Future Plans
    Table 60. AnGes Company Information, Head Office, and Major Competitors
    Table 61. AnGes Major Business
    Table 62. AnGes Gene Therapy On Cardiovascular Disease Product and Solutions
    Table 63. AnGes Gene Therapy On Cardiovascular Disease Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 64. AnGes Recent Developments and Future Plans
    Table 65. Orchard Therapeutics Company Information, Head Office, and Major Competitors
    Table 66. Orchard Therapeutics Major Business
    Table 67. Orchard Therapeutics Gene Therapy On Cardiovascular Disease Product and Solutions
    Table 68. Orchard Therapeutics Gene Therapy On Cardiovascular Disease Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 69. Orchard Therapeutics Recent Developments and Future Plans
    Table 70. Human Stem Cells Institute Company Information, Head Office, and Major Competitors
    Table 71. Human Stem Cells Institute Major Business
    Table 72. Human Stem Cells Institute Gene Therapy On Cardiovascular Disease Product and Solutions
    Table 73. Human Stem Cells Institute Gene Therapy On Cardiovascular Disease Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 74. Human Stem Cells Institute Recent Developments and Future Plans
    Table 75. Global Gene Therapy On Cardiovascular Disease Revenue (USD Million) by Players (2019-2024)
    Table 76. Global Gene Therapy On Cardiovascular Disease Revenue Share by Players (2019-2024)
    Table 77. Breakdown of Gene Therapy On Cardiovascular Disease by Company Type (Tier 1, Tier 2, and Tier 3)
    Table 78. Market Position of Players in Gene Therapy On Cardiovascular Disease, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
    Table 79. Head Office of Key Gene Therapy On Cardiovascular Disease Players
    Table 80. Gene Therapy On Cardiovascular Disease Market: Company Product Type Footprint
    Table 81. Gene Therapy On Cardiovascular Disease Market: Company Product Application Footprint
    Table 82. Gene Therapy On Cardiovascular Disease New Market Entrants and Barriers to Market Entry
    Table 83. Gene Therapy On Cardiovascular Disease Mergers, Acquisition, Agreements, and Collaborations
    Table 84. Global Gene Therapy On Cardiovascular Disease Consumption Value (USD Million) by Type (2019-2024)
    Table 85. Global Gene Therapy On Cardiovascular Disease Consumption Value Share by Type (2019-2024)
    Table 86. Global Gene Therapy On Cardiovascular Disease Consumption Value Forecast by Type (2025-2030)
    Table 87. Global Gene Therapy On Cardiovascular Disease Consumption Value by Application (2019-2024)
    Table 88. Global Gene Therapy On Cardiovascular Disease Consumption Value Forecast by Application (2025-2030)
    Table 89. North America Gene Therapy On Cardiovascular Disease Consumption Value by Type (2019-2024) & (USD Million)
    Table 90. North America Gene Therapy On Cardiovascular Disease Consumption Value by Type (2025-2030) & (USD Million)
    Table 91. North America Gene Therapy On Cardiovascular Disease Consumption Value by Application (2019-2024) & (USD Million)
    Table 92. North America Gene Therapy On Cardiovascular Disease Consumption Value by Application (2025-2030) & (USD Million)
    Table 93. North America Gene Therapy On Cardiovascular Disease Consumption Value by Country (2019-2024) & (USD Million)
    Table 94. North America Gene Therapy On Cardiovascular Disease Consumption Value by Country (2025-2030) & (USD Million)
    Table 95. Europe Gene Therapy On Cardiovascular Disease Consumption Value by Type (2019-2024) & (USD Million)
    Table 96. Europe Gene Therapy On Cardiovascular Disease Consumption Value by Type (2025-2030) & (USD Million)
    Table 97. Europe Gene Therapy On Cardiovascular Disease Consumption Value by Application (2019-2024) & (USD Million)
    Table 98. Europe Gene Therapy On Cardiovascular Disease Consumption Value by Application (2025-2030) & (USD Million)
    Table 99. Europe Gene Therapy On Cardiovascular Disease Consumption Value by Country (2019-2024) & (USD Million)
    Table 100. Europe Gene Therapy On Cardiovascular Disease Consumption Value by Country (2025-2030) & (USD Million)
    Table 101. Asia-Pacific Gene Therapy On Cardiovascular Disease Consumption Value by Type (2019-2024) & (USD Million)
    Table 102. Asia-Pacific Gene Therapy On Cardiovascular Disease Consumption Value by Type (2025-2030) & (USD Million)
    Table 103. Asia-Pacific Gene Therapy On Cardiovascular Disease Consumption Value by Application (2019-2024) & (USD Million)
    Table 104. Asia-Pacific Gene Therapy On Cardiovascular Disease Consumption Value by Application (2025-2030) & (USD Million)
    Table 105. Asia-Pacific Gene Therapy On Cardiovascular Disease Consumption Value by Region (2019-2024) & (USD Million)
    Table 106. Asia-Pacific Gene Therapy On Cardiovascular Disease Consumption Value by Region (2025-2030) & (USD Million)
    Table 107. South America Gene Therapy On Cardiovascular Disease Consumption Value by Type (2019-2024) & (USD Million)
    Table 108. South America Gene Therapy On Cardiovascular Disease Consumption Value by Type (2025-2030) & (USD Million)
    Table 109. South America Gene Therapy On Cardiovascular Disease Consumption Value by Application (2019-2024) & (USD Million)
    Table 110. South America Gene Therapy On Cardiovascular Disease Consumption Value by Application (2025-2030) & (USD Million)
    Table 111. South America Gene Therapy On Cardiovascular Disease Consumption Value by Country (2019-2024) & (USD Million)
    Table 112. South America Gene Therapy On Cardiovascular Disease Consumption Value by Country (2025-2030) & (USD Million)
    Table 113. Middle East & Africa Gene Therapy On Cardiovascular Disease Consumption Value by Type (2019-2024) & (USD Million)
    Table 114. Middle East & Africa Gene Therapy On Cardiovascular Disease Consumption Value by Type (2025-2030) & (USD Million)
    Table 115. Middle East & Africa Gene Therapy On Cardiovascular Disease Consumption Value by Application (2019-2024) & (USD Million)
    Table 116. Middle East & Africa Gene Therapy On Cardiovascular Disease Consumption Value by Application (2025-2030) & (USD Million)
    Table 117. Middle East & Africa Gene Therapy On Cardiovascular Disease Consumption Value by Country (2019-2024) & (USD Million)
    Table 118. Middle East & Africa Gene Therapy On Cardiovascular Disease Consumption Value by Country (2025-2030) & (USD Million)
    Table 119. Gene Therapy On Cardiovascular Disease Raw Material
    Table 120. Key Suppliers of Gene Therapy On Cardiovascular Disease Raw Materials
List of Figures
    Figure 1. Gene Therapy On Cardiovascular Disease Picture
    Figure 2. Global Gene Therapy On Cardiovascular Disease Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Figure 3. Global Gene Therapy On Cardiovascular Disease Consumption Value Market Share by Type in 2023
    Figure 4. Viral Gene Therapy
    Figure 5. Non-Viral Gene Therapy
    Figure 6. Global Gene Therapy On Cardiovascular Disease Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Figure 7. Gene Therapy On Cardiovascular Disease Consumption Value Market Share by Application in 2023
    Figure 8. Heart Disease Picture
    Figure 9. Vascular Disease Picture
    Figure 10. Global Gene Therapy On Cardiovascular Disease Consumption Value, (USD Million): 2019 & 2023 & 2030
    Figure 11. Global Gene Therapy On Cardiovascular Disease Consumption Value and Forecast (2019-2030) & (USD Million)
    Figure 12. Global Market Gene Therapy On Cardiovascular Disease Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
    Figure 13. Global Gene Therapy On Cardiovascular Disease Consumption Value Market Share by Region (2019-2030)
    Figure 14. Global Gene Therapy On Cardiovascular Disease Consumption Value Market Share by Region in 2023
    Figure 15. North America Gene Therapy On Cardiovascular Disease Consumption Value (2019-2030) & (USD Million)
    Figure 16. Europe Gene Therapy On Cardiovascular Disease Consumption Value (2019-2030) & (USD Million)
    Figure 17. Asia-Pacific Gene Therapy On Cardiovascular Disease Consumption Value (2019-2030) & (USD Million)
    Figure 18. South America Gene Therapy On Cardiovascular Disease Consumption Value (2019-2030) & (USD Million)
    Figure 19. Middle East and Africa Gene Therapy On Cardiovascular Disease Consumption Value (2019-2030) & (USD Million)
    Figure 20. Global Gene Therapy On Cardiovascular Disease Revenue Share by Players in 2023
    Figure 21. Gene Therapy On Cardiovascular Disease Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
    Figure 22. Global Top 3 Players Gene Therapy On Cardiovascular Disease Market Share in 2023
    Figure 23. Global Top 6 Players Gene Therapy On Cardiovascular Disease Market Share in 2023
    Figure 24. Global Gene Therapy On Cardiovascular Disease Consumption Value Share by Type (2019-2024)
    Figure 25. Global Gene Therapy On Cardiovascular Disease Market Share Forecast by Type (2025-2030)
    Figure 26. Global Gene Therapy On Cardiovascular Disease Consumption Value Share by Application (2019-2024)
    Figure 27. Global Gene Therapy On Cardiovascular Disease Market Share Forecast by Application (2025-2030)
    Figure 28. North America Gene Therapy On Cardiovascular Disease Consumption Value Market Share by Type (2019-2030)
    Figure 29. North America Gene Therapy On Cardiovascular Disease Consumption Value Market Share by Application (2019-2030)
    Figure 30. North America Gene Therapy On Cardiovascular Disease Consumption Value Market Share by Country (2019-2030)
    Figure 31. United States Gene Therapy On Cardiovascular Disease Consumption Value (2019-2030) & (USD Million)
    Figure 32. Canada Gene Therapy On Cardiovascular Disease Consumption Value (2019-2030) & (USD Million)
    Figure 33. Mexico Gene Therapy On Cardiovascular Disease Consumption Value (2019-2030) & (USD Million)
    Figure 34. Europe Gene Therapy On Cardiovascular Disease Consumption Value Market Share by Type (2019-2030)
    Figure 35. Europe Gene Therapy On Cardiovascular Disease Consumption Value Market Share by Application (2019-2030)
    Figure 36. Europe Gene Therapy On Cardiovascular Disease Consumption Value Market Share by Country (2019-2030)
    Figure 37. Germany Gene Therapy On Cardiovascular Disease Consumption Value (2019-2030) & (USD Million)
    Figure 38. France Gene Therapy On Cardiovascular Disease Consumption Value (2019-2030) & (USD Million)
    Figure 39. United Kingdom Gene Therapy On Cardiovascular Disease Consumption Value (2019-2030) & (USD Million)
    Figure 40. Russia Gene Therapy On Cardiovascular Disease Consumption Value (2019-2030) & (USD Million)
    Figure 41. Italy Gene Therapy On Cardiovascular Disease Consumption Value (2019-2030) & (USD Million)
    Figure 42. Asia-Pacific Gene Therapy On Cardiovascular Disease Consumption Value Market Share by Type (2019-2030)
    Figure 43. Asia-Pacific Gene Therapy On Cardiovascular Disease Consumption Value Market Share by Application (2019-2030)
    Figure 44. Asia-Pacific Gene Therapy On Cardiovascular Disease Consumption Value Market Share by Region (2019-2030)
    Figure 45. China Gene Therapy On Cardiovascular Disease Consumption Value (2019-2030) & (USD Million)
    Figure 46. Japan Gene Therapy On Cardiovascular Disease Consumption Value (2019-2030) & (USD Million)
    Figure 47. South Korea Gene Therapy On Cardiovascular Disease Consumption Value (2019-2030) & (USD Million)
    Figure 48. India Gene Therapy On Cardiovascular Disease Consumption Value (2019-2030) & (USD Million)
    Figure 49. Southeast Asia Gene Therapy On Cardiovascular Disease Consumption Value (2019-2030) & (USD Million)
    Figure 50. Australia Gene Therapy On Cardiovascular Disease Consumption Value (2019-2030) & (USD Million)
    Figure 51. South America Gene Therapy On Cardiovascular Disease Consumption Value Market Share by Type (2019-2030)
    Figure 52. South America Gene Therapy On Cardiovascular Disease Consumption Value Market Share by Application (2019-2030)
    Figure 53. South America Gene Therapy On Cardiovascular Disease Consumption Value Market Share by Country (2019-2030)
    Figure 54. Brazil Gene Therapy On Cardiovascular Disease Consumption Value (2019-2030) & (USD Million)
    Figure 55. Argentina Gene Therapy On Cardiovascular Disease Consumption Value (2019-2030) & (USD Million)
    Figure 56. Middle East and Africa Gene Therapy On Cardiovascular Disease Consumption Value Market Share by Type (2019-2030)
    Figure 57. Middle East and Africa Gene Therapy On Cardiovascular Disease Consumption Value Market Share by Application (2019-2030)
    Figure 58. Middle East and Africa Gene Therapy On Cardiovascular Disease Consumption Value Market Share by Country (2019-2030)
    Figure 59. Turkey Gene Therapy On Cardiovascular Disease Consumption Value (2019-2030) & (USD Million)
    Figure 60. Saudi Arabia Gene Therapy On Cardiovascular Disease Consumption Value (2019-2030) & (USD Million)
    Figure 61. UAE Gene Therapy On Cardiovascular Disease Consumption Value (2019-2030) & (USD Million)
    Figure 62. Gene Therapy On Cardiovascular Disease Market Drivers
    Figure 63. Gene Therapy On Cardiovascular Disease Market Restraints
    Figure 64. Gene Therapy On Cardiovascular Disease Market Trends
    Figure 65. Porters Five Forces Analysis
    Figure 66. Manufacturing Cost Structure Analysis of Gene Therapy On Cardiovascular Disease in 2023
    Figure 67. Manufacturing Process Analysis of Gene Therapy On Cardiovascular Disease
    Figure 68. Gene Therapy On Cardiovascular Disease Industrial Chain
    Figure 69. Methodology
    Figure 70. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Biogen
Novartis
Gilead Sciences
Sarepta Therapeutics
Alnylam Pharmaceuticals
Amgen
Spark Therapeutics
Akcea Therapeutics
bluebird bio
Sunway Biotech
SIBIONO
AnGes
Orchard Therapeutics
Human Stem Cells Institute

Related Reports

Global Gene Therapy On Cardiovascular Disease Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Global Gene Therapy On Cardiovascular Disease Market 2023 by Company, Regions, Type and Application, Forecast to 2029

date 18 Mar 2023

date Medical Devices & Consumables

Product Tags

Gene Therapy On Cardiovascular Disease

Blood Plasma Refrigerator

ENT Camera System

Medical Repair Titanium Mesh

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>